All documents required for Emergency Use Listing (EUL) have


All documents required for Emergency Use Listing (EUL) have
Image Source : PTI

All paperwork required for Emergency Use Listing (EUL) have been submitted to WHO by Bharat Biotech for COVID-19 vaccine Covaxin as of July 9 and the evaluation course of by the company has commenced, Minister of State for Health Bharati Pravin Pawar instructed Rajya Sabha on Tuesday.

Bharat Biotech has submitted all paperwork required for its COVID-19 vaccine Covaxin’s Emergency Use Listing (EUL) to the World Health Organisation (WHO) as of July 9 and the evaluation course of by the company has commenced, Minister of State for Health Bharati Pravin Pawar knowledgeable Rajya Sabha on Tuesday.

Responding to a query on whether or not it has come to the discover of the federal government that Covaxin utilized in India is just not recognised by many international locations, Pawar stated the federal government is conscious that Covaxin at current is just not a part of WHO Emergency Use Listing (EUL).

Elaborating on efforts which were made by the federal government to resolve this challenge, Pawar stated, “All documents required for Emergency Use Listing (EUL) have been submitted by Bharat Biotech International Ltd. to WHO as of 9th July 2021.”

The evaluation course of by WHO has commenced which often takes as much as six weeks to resolve on Emergency Use Listing (EUL) submissions, she stated in a written reply.

(With PTI Inputs)

ALSO READ | Bharat Biotech’s Covaxin trials for children underway; results expected by Sept: AIIMS chief

ALSO READ | Decision on Emergency Use Listing of Covaxin likely in August first week: WHO

Latest India News



Leave a Reply

Your email address will not be published. Required fields are marked *